Exodus Point Capital Management, LP Poseida Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 76,686 shares of PSTX stock, worth $231,591. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,686Holding current value
$231,591% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding PSTX
# of Institutions
93Shares Held
38.1MCall Options Held
255KPut Options Held
62K-
Pentwater Capital Management LP Naples, FL5.98MShares$18 Million0.2% of portfolio
-
Black Rock Inc. New York, NY4.95MShares$14.9 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.48MShares$13.5 Million0.74% of portfolio
-
Silverarc Capital Management, LLC3.6MShares$10.9 Million3.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.37MShares$10.2 Million0.0% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $259M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...